Core Viewpoint - The financing activities of Palin Biotech (000403) indicate a strengthening market sentiment, with a net financing purchase of 3.29 million yuan on October 22, 2025, and a total net purchase of 10.38 million yuan over the last three trading days [1][4]. Financing Summary - On October 22, 2025, the financing balance reached 729 million yuan, with a net financing purchase of 3.29 million yuan, representing 4.77% of the circulating market value [2]. - The financing activities over the past three trading days show a consistent net purchase, with the cumulative amount being 10.38 million yuan [1]. - The financing balance has shown an upward trend, increasing by 0.45% on October 22, 2025, compared to the previous day [4]. Margin Trading Summary - On October 22, 2025, the margin trading balance was 737 million yuan, reflecting a daily increase of 3.28 million yuan [4]. - The margin trading activities indicate a net short selling of 1,400 shares on October 22, 2025, with a remaining margin balance of 775,850 yuan [3]. - The overall margin trading balance has fluctuated, with a notable increase of 0.89% on October 21, 2025 [4].
派林生物:10月22日融资净买入329.05万元,连续3日累计净买入1038.09万元